Home   |     Help   |     Sitemap



...... References



1-Boussiba S.; Vonshak A.; Cohen Z.; Richmond A. (1997)
A procedure for large scale production of Astaxanthin from Haematococcus. WO 97/28274.
2- Papas, A.M. (1999)
Antioxidant Status, Diet, Nutrition, and Health. CRC Press.
3- Palozza, P. and Krinsky, N.I. (1992)
Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys. 297: 291–295.
4- Naguib, Y.M.A. (2000)
Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 48: 1150–1154.
5- Chew B.P. and Park J.S., (October 2003)
Dissertation in Supply Side West. Las Vegas .
6- Tso, M.O.M. and Lam, T-T. (1996)
Method of Retarding and Ameliorating Central Nervous System and Eye Damage. Assigned to U. S. Nutraceuticals. U.S. Patent #5527533.
7- Facchinetti F.; Dawson VL.; Dawson TM. (1998)
Free radicals as mediators of neuronal injury. Cell Mol Neurobiol.18(6):667-82 .
8- Lorenz, R.T. and Cysewski, G.R. (2000)
Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends in Biotechnol. 18: 160–167.
9 - Guerin, M.; Huntley M. E.; and Olaizola M. (2003)
Haematococcus astaxanthin: applications for human health and nutrition. Trends in Biotechnol. 21: 210-216.
10- Shibata A.; Kiba Y.; Akati N.; Fukuzawa K.; Terada H. (2001)
Molecular characteristics of astaxanthin and beta-carotene in the phospholipid monolayer and their distributions in the phospholipid bilayer. Chem Phys Lipids113(1-2): 11-22.
11- Goto S.; Kogure K.; Abe K.; Kimata Y.; Kitahama K.; Yamashita E.; Terada H. (2001)
Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim Biophys Acta1512(2): 251-8.
12- Oshima S.; Ojima F.; Sakamoto H.; Ishiguro Y.; Terao J. (1993)
Inhibitory effect of beta-carotene and astaxanthin on photosensitized oxidation of phospholipid bilayers. J Nutr Sci Vitaminol ( Tokyo ) 39(6): 607-15.
13- Kurashige M.; Okimasu E.; Inoue M.; Utsumi K. (1990)
Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR 22(1): 27-38.
14 - Nakagawa K.; Kang SD.; Park DK.; Handelman GJ.; Miyazawa T. (1997)
Inhibition of beta-carotene and astaxanthin of NADPH-dependent microsomal phospholipid peroxidation. J Nutr Sci Vitaminol ( Tokyo ) 43(3): 345-55.
15– Bahner, B. (1993)
Beta –carotene use grows; natural sector in flux. Chemical Market Reporter 244:26-27.
16- Cyanotech Corporation –
Technical paper available at: http://www.cyanotech.com/pdfs/axbul60.pdf
17 - Mera Pharmaceuticals (1999)
Haematococcus pluvialis and astaxanthin safety for human consumption.
Technical Report TR.3005.001
available at http://www.astafactor.com/techreports/tr3005-001.htm
18 – La Haye - US Nutraceuticals
technical paper available at: http://www.lahaye.com/safety.html
19- Spiller GA.; Dewell A. (2003)
Safety of an Astaxanthin-Rich Haematococcus pluvialis Algal Extract: A Randomized Clinical Trial. J Med Food 6(1): 51-6.
20- Turujman, S.A. et al. (1997)
Rapid liquid chromatographic method to distinguish wild salmon from aquacultured salmon fed synthetic astaxanthin. J. AOAC Int. 80: 622–632.
21- Mercke Odeberg J.; Lignell A.; Pettersson A.; Hoglund P. (2003)
Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci 19(4): 299-304 .
22- Clark RM.; Yao L.; She L.; Furr HC. (2000)
A comparison of lycopene and astaxanthin absorption from corn oil and olive oil emulsions. Lipids 35(7): 803-6.
23 - Snodderly D.M. (1995)
Evidence for protection against age related macular degeneration by caretonoids and antioxidant vitamins. Amer J. Clinical Nutrition. 63(s):1448S-1461S.
24- Ohgami K.; Shiratori K.; Kotake S.; Nishida T.; Mizuki N.; Yazawa K.; Ohno S. (2003)
Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci . 44(6): 2694-701.
25 - Waagbo R.; Hamre K.; Bjerkas E.; Berge R.; Wathne E.; Lie O.; Torstensen B. (2003)
Cataract formation in Atlantic salmon, Salmo salar L., smolt relative to dietary pro- and antioxidants and lipid level . J Fish Dis. 26(4): 213-29.
26- O'Connor I.; O'Brien N. (1998)
Modulation of UVA light-induced oxidative stress by beta-carotene, lutein and astaxanthin in cultured fibroblasts. J Dermatol Sci . 16(3): 226-30.
27 - Malmsten C. (1998)
Dietary supplementation with astaxanthin rich algal meal improves muscle endurance – a double blind study on male students. Unpublished study from the Karolinska Institute. Gustavberg , Sweden .
28- Lignell A. (2001)
Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseased. US patent # 6,245,818 Astacarotene AB Sweden .
29- Bennedsen, M. et al. (1999)
Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol. Lett. 70: 185–189.
30- Wang X.; Willen R.; Wadstrom T. (2000)
Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob Agents Chemother 44(9): 2452-7.
31-Lignell, A. (1998)
Treatment of Dyspepsia, Patent no. WO 00/23064
32- Anderson T.; Pettersson S. (2001)
Method of inhibiting the expression of inflammatory cytokines. Patent no. WO 0172296.
33- Lorenz T. et al. (2000)
Method of retarding Ameliorating Carpel tunnel syndrome, US Patent #. 6,258,855.
34- Hughes D.A. (1999)
Effects of dietary antioxidants on the immune function of the middle aged. Proc. Nutr. Soc 58(1): 79-84.
35- Lignell A. (2001)
Use of xanthophylls, Astaxanthin e.g. for the treatment of autoimmune diseases, chronic viral and intracellular bacterial infections. Patent # WO 01/24787.
36- Lignell A. et al. (1998)
Method for the prophylactic treatment of mastitis. WO99/30701.
37- Jyonouchi, H. et al. (1995)
Effect of carotenoids on in vitro immunoglobulin production by human peripheral blood mononuclear cells: astaxanthin, a carotenoid without vitamin A activity, enhances in vitro immunoglobulin production in response to a T-dependent stimulant and antigen. Nutr. Cancer 23: 171–183.
38- Lee SJ.; Bai SK.; Lee KS.; Namkoong S.; Na HJ.; Ha KS.; Han JA.; Yim SV.; Chang K.; Kwon YG.; Lee SK.; Kim YM. (2003)
Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation. Mol Cells Korea 16(1): 97-105.
39- Chew BP.; Wong MW.; Park JS.; Wong TS. (1999)
Dietary beta-carotene and astaxanthin but not canthaxanthin stimulate splenocyte function in mice. Anticancer Res. 19(6B): 5223-7.
40- Jyonouchi H.; Zhang L.; Tomita Y. (1993)
Studies of immunomodulating actions of carotenoids. II. Astaxanthin enhances in vitro antibody production to T-dependent antigens without facilitating polyclonal B-cell activation. Nutr Cancer 19(3): 269-80.
41- Jyonouchi H.; Hill RJ.; Tomita Y.; Good RA. (1991)
Studies of immunomodulating actions of carotenoids. I. Effects of beta-carotene and astaxanthin on murine lymphocyte functions and cell surface marker expression in in vitro culture system. Nutr Cancer 16(2): 93-105.
42- Akyon Y. (2002 )
Effect of antioxidants on the immune response of Helicobacter pylori. Clin Microbiol Infect. 8(7): 438-41.
43- Okai Y.; Higashi-Okai K. (1996)
Possible immunomodulating activities of carotenoids in in vitro cell culture experiments. Int J Immunopharmacol 18(12): 753-8.
44- Jyonouchi H.; Sun S.; Mizokami M.; Gross MD. (1996)
Effects of various carotenoids on cloned, effector-stage T-helper cell activity. Nutr Cancer 26(3): 313-24.
45- Jyonouchi H.; Sun S.; Tomita Y.; Gross MD. (1995)
Astaxanthin, a carotenoid without vitamin A activity, augments antibody responses in cultures including T-helper cell clones and suboptimal doses of antigen. J Nutr 125(10): 2483-92.
46- Jyonouchi H.; Zhang L.; Gross M.; Tomita Y. (1994)
Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr Cancer 21(1): 47-58.
47- Murillo E. (1992)
Cholesterolemic effects of canthaxanthin & astaxanthin in rats. Arc Latinoam Nutr. 42: 409-13.
48- Iwamoto T.; Hoosoda K.; Hirano R.; Kurata H.; Matsumoto A.; Miki W.; Kamiyama M.; Itakaru H.; Yamamoto S.; Kondo K. (2001)
Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb 7: 216-22
49- Zhang LX.; Cooney RV.; Bertram JS. (1991)
Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. in C3H/10T1/2 cells: relationship to their cancer chemopreventative action. Carcinogenesis 12(11): 2109-14.
50- Aoi W.; Naito Y.; Sakuma K.; Kuchide M.; Tokuda H.; Maoka T.; Toyokuni S.; Oka S.; Yasuhara M.; Yoshikawa T. (2003)
Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxid Redox Signal 5(1): 139-44.
51- Kang JO.; Kim SJ.; Kim H. (2001)
Effect of astaxanthin on the hepatotoxicity, lipid peroxidation and antioxidative enzymes in the liver of CCl4-treated rats. Methods Find Exp Clin Pharmacol. 23(2): 79-84.
52- Murillo E. (1992)
Hypercholesterolemic effect of canthaxanthin and astaxanthin in rats. Arch Latinoam Nutr 42(4): 409-13.
53-Rengel D.; Diez-Navajas A.; Serna-Rico A.; Veiga P.; Muga A.; Milicua JC. (2000) Exogenously incorporated ketocarotenoids in large unilamellar vesicles. Protective activity against peroxidation. Biochim Biophys Acta 1463(1): 179-87.
54- Jyonouchi H.; Sun S.; Iijima K.; Gross MD. (2000)
Antitumour activity of astaxanthin and its mode of action. Nutr cancer 36(1): 59-65.
55- Kurihara H.; Koda H.; Asami S.; Kiso Y.; Tanaka T. (2002)
Contribution of the anti oxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with resistant stress. Life Sci. 70(21): 2509-20.
56- Tanaka T.; Makita H.; Ohnishi M.; Mori H.; Satoh K.; Hara A. (1995)
Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res. 55 (18): 4059-4064.
57- Tanaka T.; Morishita Y.; Suzui M.; Kojima T.; Okumura A.; Mori H. (1994) Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 15(1): 15-19.
58- Tanaka T.; Kawamori T.; Ohnishi M.; Makita H.; Mori H.; Satoh K.; Ha A. (1995) Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis 16(12): 2957-63.
59- Rousseau EJ.; Davison AJ.; Dunn B. (1992)
Protection by beta-carotene and related compounds against oxygen-mediated cytotoxicity and genotoxicity: implications for carcinogenesis and anticarcinogenesis. Free Radic Biol Med 13(4): 407-33.
60- Kozuki Y.; Miura Y.; Yagasaki K. (2000)
Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Lett 151(1): 111-5
61- Gradelet S.; Le Bon AM.; Berges R.; Suschetet M.; Astorg P. (1998)
Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism. Carcinogenesis (3): 403-11.
62- Black HS. (1998)
Radical interception by carotenoids and effects on UV carcinogenesis. Nutr Cancer 31(3): 212-7.
63 - Nishino H.; Murakosh M.; Ii T.; Takemura M.; Kuchide M.; Kanazawa M.; Mou XY.; Wada S.; Masuda M.; Ohsaka Y.; Yogosawa S.; Satomi Y.; Jinno K. (2002)
Carotenoids in cancer chemoprevention. Cancer Metastasis Rev. 21(3-4): 257-64.
64- Li Z.; Wang Y.; Mo B. (2002)
The effects of carotenoids on the proliferation of human breast cancer cell and gene expression of bcl-2. Zhonghua Yu Fang Yi Xue Za Zhi. 36(4): 254-7.
65- Chew BP.; Park JS.; Wong MW.; Wong TS. (1999)
A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res 19(3A): 1849-53.
66- Hansen KB.; Tauson AH.; Inborr J. (2001)
Effect of supplementation with the antioxidant astaxanthin on reproduction, pre-weaning growth performance of kits and daily milk intake in mink. J Reprod Fertil Suppl. 57: 331-4.
67- Lignell et al. (1998)
Method of increasing the production and improving the quality of semen. WO99/29313.
68- Lyons NM.; O'Brien NM. (2002)
Modulatory effects of an algal extract containing astaxanthin on UVA-irradiated cells in culture. J Dermatol Sci (1): 73-84.
69- Savoure N.; Briand G.; Amory-Touz MC.; Combre A.; Maudet M.; Nicol M. (1995) Vitamin A status and metabolism of cutaneous polyamines in the hairless mouse after UV irradiation: action of beta-carotene and astaxanthin. Int J Vitam Nutr Res 65(2): 79-86.
70- Skin et al. (2001)
Effects of astaxanthin from Haematococcus pluvialis on human skin. Fragrance Journal 12: 98-103.
71- Yamahita et al, (1995)
Suppression of post-UVB hyperpigmention by topical astaxanthin from krill. Fragrance Journal 14: 180-185.
72- R. Todd Lorenz.
Method for retarding and preventing sunburn by UV light. R. Patent no. US 6,433,025 B1 Cyanotech corporation.
73- Anderson, M. (2001)
Method of Inhibiting 5-a Reductase with Astaxanthin to Prevent and Treat Benign Prostate Hyperplasia (BPH) and Prostate Cancer in Human Males. US Patent #6277417.
74- Osterlie M.; Bjerkeng B.; Liaaen-Jensen S. (1999)
On bioavailability and deposition of bent Z-isomers of astaxanthin. In: Pigments in Food Technology. Proceedings of 1st International Congress PFT (Minguez Mosquera, M. I., Galan, M. J. & Mendez, D. H., eds) pp. 157-161. International Congress on Pigments in Food Technology, Sevilla, Spain
75- Osterlie M.; Bjerkeng B.; Liaaen-Jensen S. (1999)
Blood appearance and distribution of astaxanthin E/Z isomers among plasma lipoproteins in humans administered in a single meal with astaxanthin. Abstract 2A-13. Presented at the 12th International Symposium on Carotenoids in Cairns , Queensland , Australia , July 18-23, 1999.
76 - Osterlie M.; Bjerkeng B.; Liaaen-Jensen, S. (2000)
Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J. Nutr. Biochem. 11: 482-490.



About Us    |   FAQ    |   Affiliates    |    Contacts    |  Policy    |    Help    |    Sitemap

Copyright © America Sunshine Group, Inc. 2006. All Rights Reserved

Powerd by CompSupport